Clark Eliana 4
4 · Intellia Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2024-07-01$22.93/sh−405$9,287→ 71,470 total
Footnotes (1)
- [F1]Sale of 405 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 28, 2024.